BB
Benjamin Burnett Wells Fargo Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
25
Avg Return
Past Year
Past Year
13%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
76%
Neutral
24%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Equal-Weight
Maintained
| $22.50 |
5%
upside
| 3 | – |
–
| 20 Nov ‘25 7 days ago |
|
|
|
Overweight
Maintained
| $35 |
21%
upside
| 3 | +19% |
0
%
| 13 Nov ‘25 14 days ago |
|
|
|
Overweight
Maintained
| $37 |
24%
upside
| 3 | +0.46% |
0
%
| 13 Nov ‘25 14 days ago |
|
|
|
Overweight
Maintained
| $16 |
109%
upside
| 1 | +8.8% |
0
%
| 11 Nov ‘25 16 days ago |
|
|
|
Overweight
Maintained
| $8 |
49%
upside
| 1 | -0.74% |
0
%
| 11 Nov ‘25 16 days ago |
|
|
|
Overweight
Maintained
| $23 |
31%
upside
| 1 | +2.7% |
0
%
| 11 Nov ‘25 16 days ago |
|
|
|
Overweight
Maintained
| $93 |
8%
upside
| 1 | +27% |
0
%
| 5 Nov ‘25 22 days ago |
|
|
|
Overweight
Maintained
| $44 |
1%
downside
| 2 | +6.4% |
0
%
| 4 Nov ‘25 23 days ago |
|
|
|
Overweight
Maintained
| $157 |
4%
upside
| 2 | +11% |
0
%
| 4 Nov ‘25 23 days ago |
|
|
|
Equal-Weight
Maintained
| $423 |
13%
downside
| 1 | – |
–
| 30 Oct ‘25 28 days ago |
|
|
|
Buy
Maintained
| $64 |
18%
downside
| 2 | +53% |
0
%
| 1 Apr ‘25 8 months ago |
|
|
|
Hold
Maintained
| $3 |
173%
upside
| 1 | – |
–
| 6 Mar ‘25 8 months ago |
|
|
|
Hold
Maintained
| $49 |
8%
downside
| 1 | – |
–
| 13 Feb ‘25 9 months ago |
|
|
|
Buy
Maintained
| $94 |
0%
upside
| 2 | +26% |
0
%
| 24 Jan ‘25 10 months ago |
|
|
|
Buy
Maintained
| $4 |
81%
upside
| 1 | -44% |
0
%
| 13 Dec ‘24 11 months ago |
|